Bio
Robin van der Meulen is a Partner in Scott+Scott’s New York office. She has more than 15 years of experience litigating a wide variety of antitrust matters, including price-fixing, monopolization, benchmark and commodities manipulation, pay-for-delay agreements, and other anticompetitive practices. Robin has served as lead or co-lead counsel for end-payor plaintiffs in several pay-for-delay antitrust class actions and recently recovered $30 million for end-payor plaintiffs in the Novartis and Par Antitrust Litigation, a pay-for-delay case relating to the hypertension drug Exforge. In addition, Robin recently led a no-poach case alleging that companies in the aerospace industry conspired to restrict competition in the recruitment and hiring of engineers and other skilled workers and negotiated $26.5 million in partial settlements.
The Legal 500 recommends Robin for excellence in the field of Antitrust Civil Litigation and Class Actions, describing her as "persistent, persuasive, and well-respected by peers and opponents alike." She has also been selected to Benchmark’s "40 & Under Hot List" as one of "the best and brightest law firm partners" and someone who is "ready to take the reins." Chambers highlights that "Robin has great presence. She is deliberative, prudent and smart," and is "[a] great lawyer who is very savvy and strategic."
Robin also devotes substantial time as a leader in the antitrust bar. She is a past-Chair of the Antitrust Law Section of the New York State Bar Association (2024). Robin is also co-chair of the Insurance and Financial Services Committee of the Antitrust Section of the American Bar Association (ABA). And she was previously a vice chair of the Antitrust Section’s Health Care & Pharmaceutical Committee of the ABA.
Prior to joining Scott+Scott, Robin was a partner in a nationally recognized antitrust practice group and before that an associate at Willkie Farr & Gallagher LLP, where she practiced antitrust and commercial litigation. She also served as a judicial intern in the United States Bankruptcy Court for the Eastern District of New York for Judge Elizabeth S. Stong. While in college, Robin was a member of Columbia University’s Division I Track and Field team, specializing in hurdles and sprints.
SPEAKING ENGAGEMENTS / PANELS:
- Panelist, "Strategies for Handling Virtual Depositions," Practising Law Institute (March 2023, March 2025 & March 2026)
- Panelist, "Defensive Discovery in Antitrust Litigation," American Bar Association Antitrust Law Section (Nov. 13, 2025)
- Panelist, "The 2025 Milton Handler Lecture on Antitrust," New York City Bar
- Chair of the NYSBA Antitrust Law Section Annual Meeting and Dinner (January 2024)
- Panelist, "Discovery in Class Action Litigation," Practising Law Institute (December 2023)
- Moderator, "Do Not Pass Go – Steering and Monopolies," ABA Section of Antitrust Law Spring Meeting (March 2023)
- Panelist, "Antitrust and the Supreme Court," New York State Bar Association – Antitrust Law Section Annual Meeting (January 2023)
- Panelist, "What’s New in Reverse Payment Litigation," ABA Sections of Antitrust Law & Health Law (February 2021)
PUBLICATIONS / ARTICLE QUOTES:
- Author: "Antitrust Law Continues Its Turn in the Spotlight," New York Law Journal (Jan. 13, 2025)
- Quoted in: "PBMs Will Stay in Crosshairs as Trump Antitrust Team Settles in," Katie Arcieri and Nyah Phengsitthy, Bloomberg Law (Dec. 30, 2024)
- Quoted in: Law.com’s "How I Made Partner" feature (Feb. 22, 2021)
- Co-Author: "An Update On Anti-Poach Enforcement And Class Actions," Law360 (July 12, 2018)
- Co-Author: "Cash or No Cash – That is No Longer the Question," Antitrust Health Care Chronicle (Apr. 22, 2016)
- Co-Author: "What’s Located in Washington, Part of the Government and Rolling in Dough?" Bloomberg BNA Daily Report for Executives (Mar. 12, 2014)
Highlights
- Lawdragon: 500 Leading Global Antitrust & Competition Lawyers (2025)
- The Legal 500 "Next Generation Partner" (2021-2026)
- Chambers USA: "Up and Coming" (2021-2023)
- Chambers USA: Band 3, Antitrust: Mainly Plaintiff, New York (2025-2026)
- Benchmark Litigation "Future Star" (2021-2026)
- Benchmark’s "40 & Under Hot List" (2021)
- Euromoney’s Women in Business Law Awards: Antitrust and Competition Lawyer of the Year Finalist (2021)
- The Best Lawyers in America®: Antitrust Law (2022-2026)
- Former Chair of the Antitrust Law Section of the New York State Bar Association (2024)
- Chair, Insurance and Financial Services Committee, Antitrust Section of the ABA (2023-2025)
- New York Metro Super Lawyer (2025-2026), Antitrust Litigation
Admissions
- State of New York
- United States Court of Appeals: Second Circuit
- United States District Court for the Southern District of New York
- United States District Court for the Eastern District of New York
- United States District Court for the Northern District of New York
Representative Cases
- Borozny, et al. v. RTX, Pratt & Whitney Division, et al., No. 3:21-cv-01657 (D. Conn.)
- In re Novartis and Par Antitrust Litigation (Exforge), No. 1:18-cv-04361 (S.D.N.Y.)
- In re Generic Pharmaceuticals Pricing Antitrust Litigation, No. 2:16-md-02724 (E.D. Pa.)
- Alaska Electrical Pension Fund v. Bank of America (ISDAFix), No. 1:14-cv-07126 (S.D.N.Y.)
Education
- Brooklyn Law School (J.D.)
- Columbia College, Columbia University (B.A.)